Fig. 1

Adjusted hazard ratios for the association between hormone replacement therapy use after diagnosis and cancer-specific mortality in England (
), Scotland (
), Wales (
) and pooled (
), by site.

Adjusted hazard ratios for the association between hormone replacement therapy use after diagnosis and cancer-specific mortality in England (
), Scotland (
), Wales (
) and pooled (
), by site.